SARS-CoV-2 In article number 2311537 by Jincun Zhao, Xun Sun, and co-workers, a specific ACE2-binding peptide with a superior antiviral activity was identified and used to modified the inhaled nanoemulsions. The inhaled remdesivir nanoemulsions strongly inhibit SARS-CoV-2 not only by blocking the binding of virus to host cells at the cell surface but also restricting virus replication intracellularly.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: